Advertisement

Reactions Weekly

, Volume 1746, Issue 1, pp 179–179 | Cite as

Secukinumab

Nasopharyngitis, oral candidiasis and Crohn's disease: 3 case reports
Case report
  • 18 Downloads

Reference

  1. Tsentemeidou A, et al. Real-life efficacy and safety of secukinumab: results from a tertiary hospital in Greece. Journal of the European Academy of Dermatology and Venereology 33: e50-e51, No. 2, Feb 2019. Available from: URL: http://doi.org/10.1111/jdv.15165 - Greece

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations